Publications by authors named "C-Y Su"

Background: Xalnesiran, a small interfering RNA molecule that targets a conserved region of the hepatitis B virus (HBV) genome and silences multiple HBV transcripts, may have efficacy, with or without an immunomodulator, in patients with chronic HBV infection.

Methods: We conducted a phase 2, multicenter, randomized, controlled, adaptive, open-label platform trial that included the evaluation of 48 weeks of treatment with xalnesiran at a dose of 100 mg (group 1), xalnesiran at a dose of 200 mg (group 2), xalnesiran at a dose of 200 mg plus 150 mg of ruzotolimod (group 3), xalnesiran at a dose of 200 mg plus 180 μg of pegylated interferon alfa-2a (group 4), or a nucleoside or nucleotide analogue (NA) alone (group 5) in participants with chronic HBV infection who had virologic suppression with NA therapy. The primary efficacy end point was hepatitis B surface antigen (HBsAg) loss (HBsAg level, <0.

View Article and Find Full Text PDF

Background: The kinetics of serum hepatitis B surface antigen (HBsAg) levels during long-term nucleos(t)ide analogue (NA) therapy remains unclear. We delineated the kinetics of HBsAg and analyzed its association with long-term treatment outcomes.

Methods: We enrolled 912 treatment-naïve patients with chronic hepatitis B (CHB) who had received NA therapy for >12 months and analyzed the kinetic patterns through group-based trajectory models (GBTMs).

View Article and Find Full Text PDF

Purpose: To elucidate the genetic basis of primary angle-closure glaucoma (PACG) by identifying pathogenic tissue and critical tissue-specific variants.

Methods: The correlations among PACG susceptibility, axial length (AL), and anterior chamber depth (ACD) were evaluated using meta-analyses. Propensity score matching was utilized on 2161 participants from the Handan Eye Study to determine the risk factors independent of ACD and AL for PACG.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigated the effectiveness of lenvatinib in treating unresectable hepatocellular carcinoma (HCC) and identified key factors influencing patient survival.
  • This involved analyzing data from 53 patients on lenvatinib monotherapy and 19 patients on a combination therapy of lenvatinib and immune checkpoint inhibitors.
  • The results showed that while the combination therapy had a higher response rate, there were no significant differences in progression-free survival or overall survival between the two groups, although specific patient criteria from the monotherapy group indicated better outcomes.
View Article and Find Full Text PDF

Background: Play is an indispensable and meaningful activity in children's daily life. Research has shown that autistic children often exhibit differences in play development. The core traits of autism, such as distinct patterns in social interaction and communication, focused interests, and repetitive behaviors, frequently manifest in their play.

View Article and Find Full Text PDF

Cyclin-dependent kinases 12/13 play pivotal roles in orchestrating transcription elongation, DNA damage response, and maintenance of genomic stability. Biallelic CDK12 loss has been documented in various malignancies. Here, we develop a selective CDK12/13 PROTAC degrader, YJ9069, which effectively inhibits proliferation in subsets of prostate cancer cells preferentially over benign immortalized cells.

View Article and Find Full Text PDF

Delivering synthetic protein-coding RNA bypassing the DNA stage for ectopic protein functioning is a novel therapeutic strategy. Joining the linear RNA head-to-tail covalently could be a state-of-the-art strategy for functioning longer. Here we enroll a cis-acting ligase ribozyme (RzL) to generate circular RNA (circRNA) in vitro for ectopic protein expression.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to compare the effectiveness and tolerability of two treatments for chronic migraine: CGRP monoclonal antibodies (mAbs) and onabotulinumtoxinA.
  • It included 649 chronic migraine patients and found that CGRP mAbs reduced monthly migraine days more significantly than onabotulinumtoxinA and had a higher responder rate.
  • Both treatments were well-tolerated, with fewer adverse events reported for CGRP mAbs, but further studies are needed to confirm these results.
View Article and Find Full Text PDF

Background: This study aimed to investigate the association between the temporal transitions in heart rhythms during cardiopulmonary resuscitation (CPR) and outcomes after out-of-hospital cardiac arrest.

Methods: This was an analysis of the prospectively collected databases in 3 academic hospitals in northern and central Taiwan. Adult patients with out-of-hospital cardiac arrest transported by emergency medical service between 2015 and 2022 were included.

View Article and Find Full Text PDF

Purpose: To evaluate the correlation between suture contamination and rotator cuff tendon retear after arthroscopic rotator cuff repair.

Methods: Patients undergoing primary arthroscopic rotator cuff repair from April 1, 2020, to September 30, 2022, were enrolled. Those younger than 18 years, with a history of shoulder surgeries or shoulder infection episodes, or who declined participation were excluded.

View Article and Find Full Text PDF

Introduction: Field factors play more important roles in predicting the outcomes of patients compared with tumor factors in early-stage hepatocellular carcinoma (HCC). However, the prognostic ability of noninvasive serum marker scores for hepatic fibrosis and liver functional reserve on very early-stage HCC is still not yet determined. We aimed to investigate the performance of these serum marker scores in predicting the prognoses of patients with very early-stage HCC.

View Article and Find Full Text PDF

Gastroesophageal reflux disease (GERD) is associated with an incompetent lower esophageal sphincter (LES), resulting in the reflux of gastric contents into the esophagus. U46619, a thromboxane A2 (TXA2) receptor agonist, induces contractions in various smooth muscles. Therefore, this study aimed to investigate the effects and mechanisms of action of U46619 on the porcine LES.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to identify biomarkers for endometriosis and create a diagnostic model validated by clinical samples.
  • Researchers utilized public data and machine learning to fashion a nine-gene panel called EMScore, effectively differentiating between endometriosis patients and healthy individuals.
  • The model demonstrated high accuracy, achieving receiver operator characteristic curve values of 0.920 for tissue samples and 0.942 for blood samples, confirming its potential as a reliable diagnostic tool.
View Article and Find Full Text PDF

Cell expansion of human pluripotent stem cells (hPSCs) commonly depends on Matrigel as a coating matrix on two-dimensional (2D) culture plates and 3D microcarriers. However, the xenogenic Matrigel requires sophisticated quality-assurance processes to meet clinical requirements. In this study, we develop an innovative coating-free medium for expanding hPSCs.

View Article and Find Full Text PDF

Background: Variants in the gene, that encodes the cytoskeletal protein, dystrophin, cause a severe form of dilated cardiomyopathy (DCM) associated with high rates of heart failure, heart transplantation, and ventricular arrhythmias. Improved early detection of individuals at risk is needed.

Methods: Genetic testing of 40 male probands with a potential X-linked genetic cause of primary DCM was undertaken using multi-gene panel sequencing, multiplex polymerase chain reaction, and array comparative genomic hybridization.

View Article and Find Full Text PDF

Atherosclerotic plaques form in the inner layer of arteries triggering heart attacks and strokes. Although T cells have been detected in atherosclerosis, tolerance dysfunction as a disease driver remains unexplored. Here we examine tolerance checkpoints in atherosclerotic plaques, artery tertiary lymphoid organs and lymph nodes in mice burdened by advanced atherosclerosis, via single-cell RNA sequencing paired with T cell antigen receptor sequencing.

View Article and Find Full Text PDF

Objective: To understand the clinical risks associated with the transfer of embryos classified as a mosaic using preimplantation genetic testing for aneuploidy.

Design: Analysis of data collected between 2017 and 2023.

Setting: Multicenter.

View Article and Find Full Text PDF

Background: Anti-β2GP1 (β2-glycoprotein 1) antibodies are the primary pathogenic antibody to promote thrombosis in antiphospholipid syndrome (APS), yet the underlying mechanism remains obscure. We aimed to explore the intracellular pathway that mediated platelet activation.

Methods: Platelets were isolated from patients with APS and subjected to RNA sequencing.

View Article and Find Full Text PDF

Synthetic macrocyclic peptides are an emerging molecular class for both targeting intracellular protein-protein interactions (PPIs) and providing an oral modality for drug targets typically addressed by biologics. Display technologies, such as mRNA and phage display, often yield peptides that are too large and too polar to achieve passive permeability or oral bioavailability without substantial off-platform medicinal chemistry. Herein, we use DNA-encoded cyclic peptide libraries to discover a neutral nonapeptide, UNP-6457, that inhibits MDM2-p53 interaction with an IC of 8.

View Article and Find Full Text PDF

Background: As a part of natural disease progression, acute kidney injury (AKI) can develop into chronic kidney disease via renal fibrosis and inflammation. LTBP4 (latent transforming growth factor beta binding protein 4) regulates transforming growth factor beta, which plays a role in renal fibrosis pathogenesis. We previously investigated the role of LTBP4 in chronic kidney disease.

View Article and Find Full Text PDF

The Taiwan Biobank (TWB) is an ongoing prospective study of >150,000 individuals aged 20-70 in Taiwan. A comprehensive list of phenotypes was collected for each consented participant at recruitment and follow-up visits through structured interviews and physical measurements. Biomarkers and genetic data were generated from blood and urine samples.

View Article and Find Full Text PDF
Article Synopsis
  • A randomized, double-blind, phase 2 trial assessed the safety and effectiveness of a new vaccine, NVSI-06-09, as a booster for UAE adults previously vaccinated with BBIBP-CorV.
  • * The trial involved 516 participants who received either NVSI-06-09 or continued with BBIBP-CorV, showing a similar low incidence of mild adverse reactions in both groups.
  • * Results indicated that NVSI-06-09 produced significantly higher neutralizing antibody levels against various SARS-CoV-2 variants, including significantly better responses against Omicron strains compared to BBIBP-CorV.
View Article and Find Full Text PDF